In vivo and in vitro effect of spironolactone on hepatic fibrosis of rat

LI Xu,MENG Ying,ZHANG Zhen-Shu,ZHANG Xiao-Lan,HUANG Mao-Liang

DOI: https://doi.org/10.3321/j.issn:1000-2790.2008.05.006

2008-01-01

Abstract:AIM:To determine the effect of spironolactone on the progression of rat hepatic fibrosis in vivo and in vitro and its mechanisms.METHODS:Twenty-four Wistar rats weighing about 250 g were divided into 3 groups,with 8 in each group.In model group,the rats received injection of 40% CCl4 2.5 mL/kg subcutaneously,three times a week.In spironolactone treatment group,the rats received injection of 40% CCl4 as well as ig administration of spironolactone 20 mg/(kg·d).In control group,the rats received injection of olive oil only.After 4 weeks,morphological examination was performed.The expression of TGF-β1 protein in liver tissue was examined by Western Blot.Electrophoretic gel mobility shift assay(EMSA)was utilized to detect NF-κB DNA binding activity in liver tissues.The activities of matrix metalloproteinase-2,9(MMP-2,9)were assessed by zymography.In vitro,HSC(hepatic stellate cell)-T6 cells were preincubated for 1 h with or without spironolactone 1 μmol/L(an inhibitor of aldosterone)prior to exposure to aldosterone(Aldo)1 μmol/L for 1 h.DNA binding activity of NF-κB was analyzed by EMSA.The expression of IκBα protein was examined by Western Blot.RESULTS:In vivo,spironolactone treatment significantly reduced mean fibrosis score and protein levels of TGF-β1 in the 4th week(P<0.01,P<0.05).Spironolactone reduced DNA binding activity of NF-κB and MMP-2,9 activities(P<0.01).In vitro,stimulation of HSC by Aldo increased NF-κB DNA binding activity(P<0.01)and decreased IκBα protein expression(P<0.05).On the contrary,spironolactone significantly reduced NF-κB DNA binding activity and increased IκBα protein expression(P<0.05).CONCLUSION:Spironolactone may partly exert inhibiting effects on CCl4-induced hepatic fibrogenesis by reducing TGF-β1 expression,inhibiting DNA binding activity of NF-κB and activities of MMP-2,9.Stimulation of HSC by Aldo promotes NF-κB binding activity which can be inhibited by spironolactone.